Where does Population BIO, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Population BIO, Inc. ranks #15,541 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Population BIO, Inc. hold?

Population BIO, Inc. holds 19 US utility patents granted between 2018 and 2024, spanning 8 technology areas.

What is Population BIO, Inc.'s Innovation Score?

Population BIO, Inc. has an Innovation Score of 33.9 out of 100 (top 54% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Population BIO, Inc.'s patent grant rate increasing or decreasing?

Population BIO, Inc.'s recent grant velocity is +38% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Population BIO, Inc.'s patents?

Population BIO, Inc.'s patents average 17.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Population BIO, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Population BIO, Inc.

Q: What technology areas does Population BIO, Inc. focus on?

Population BIO, Inc.'s top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 19 patents. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 19 granted patents across 8 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Population ranks #15,541 of 50,000 tracked US assignees by granted-patent volume, with 19 patents across 8 technology areas.

#15,541
of 50,000 US assignees by volume: Top 54%
by Innovation Score (33.9/100): 17.9
avg claims per patent: +38%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15541 · US Corporation #15,541 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 19 grants
MID-PACK #15,541/50,000
PHOTO-FINISH PHARMAKEA
CPC-NARROW C12Q · 8 areas
INNOV-THIN 33.9/100
CLAIMS-RICH 17.9 claims/avg
TYPE-USCORP US Corporation
VEL-UP +38% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pharmakea, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Population BIO · this assignee

34
3D Lighting Innovati… · lowest

7

What this shows Population BIO, Inc. stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-NARROW, INNOV-THIN, CLAIMS-RICH, TYPE-USCORP, VEL-UP, BOOK-FULL. Volume places it #15,541 of 50,000; Innovation Score 33.9/100 sits in the top 54% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Pharmakea, Inc. (±0 grants).

Portfolio overview

Population BIO, Inc. has been granted 19 US utility patents between 2018 and 2024, placing Population BIO, Inc. at #15,541 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.9 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, Population BIO, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Population sits between Pharmakea, Inc. (19 patents, rank #15,523) and Preferred Technology, Llc (19 patents, rank #15,531) - the closest US assignees by grant volume. The composite Innovation Score of 33.9/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 11 grants, compared with 8 in the 2015–2019 window, a +38% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Population BIO, Inc.'s 17.9 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 8 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Pharmakea

19
Pikolinos DISEÑO…

19
Pluristem

19
Polatechno

19
PQ

19
Pqsecure

19
Preco

19
Preferred Technol…

19
Population BIO ◀

19

What this shows Population holds 19 patents at rank #15,527, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Population

By rank, the assignees closest to #15,527 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Population's primary technology class.

Population's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 Top 54% higher than 46% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Population BIO, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	10.5%
2019	6	31.6%
2020	3	15.8%
2021	3	15.8%
2022	1	5.3%
2023	3	15.8%
2024	1	5.3%

Which technologies does Population BIO, Inc. patent most?

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 19

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 5

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 3

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 2

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 2

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2

C07K - PEPTIDES 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#15,541

of 50,000 tracked assignees

Innovation Score

33.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.